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Abstract Dietary flaxseed has cardioprotective effects
that may be achieved through its rich content of the omega-
3 fatty acid, alpha linolenic acid (ALA). Because ALA can
be stored in adipose tissue, it is possible that some of its
beneficial actions may be due to effects it has on the adi-
pose tissue. We investigated the effects of dietary flaxseed
both with and without an atherogenic cholesterol-enriched
diet to determine the effects of dietary flaxseed on the
expression of the adipose cytokines leptin and adiponectin.
Rabbits were fed one of four diets: a regular (RG) diet, or a
regular diet with added 0.5% cholesterol (CH), or 10%
ground flaxseed (FX), or both (CF) for 8 weeks. Levels of
leptin and adiponectin expression were assessed by RT-
PCR in visceral adipose tissue. Consumption of flaxseed
significantly increased plasma and adipose levels of ALA.
Leptin protein and mRNA expression were lower in CH
animals and were elevated in CF animals. Changes in
leptin expression were strongly and positively correlated
with adipose ALA levels and inversely correlated with
levels of en face atherosclerosis. Adiponectin expression
was not significantly affected by any of the dietary inter-
ventions. Our data demonstrate that the type of fat in the
diet as well as its caloric content can specifically influence
leptin expression. The findings support the hypothesis that
the beneficial cardiovascular effects associated with flax-
seed consumption may be related to a change in leptin
expression.
Keywords Flaxseed  Alpha linolenic acid  Adipokine 
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Abbreviations
ALA Alpha linolenic acid
LDL Low density lipoprotein
eNOS Endothelial nitric oxide synthase
RG Regular rabbit diet
CH Regular diet supplemented with 0.5%
cholesterol
FX Regular diet supplemented with 10% ground
flaxseed
CF Regular diet supplemented with 0.5%
cholesterol and 10% ground flaxseed
EDTA Ethylenediaminetetraacetic acid
ANOVA Analysis of variance
LSD Least significant difference
GC Gas chromatography
SREBP Sterol response element binding protein
C/EBP CCAAT-enhancer-binding protein
PPAR Peroxisome proliferator-activated receptor
Introduction
Adipocytes, the cells that make up the bulk of adipose
tissue in the body, have an important physiological role
beyond their lipid storage capacity. They secrete a number
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of important cellular signaling molecules, termed adipo-
kines. These adipokines have consequences ranging from
local autocrine and paracrine effects to systemic endocrine
actions. Adipokines also vary widely in both their function
and mechanisms of control. One such mechanism of con-
trol is the fatty acid composition of adipose tissue which
can affect cellular signaling, fatty acid trafficking, gene
expression and, consequently, metabolism [1]. Adipose
tissue composition varies based on two main effectors:
energy balance, which regulates the metabolism of free
fatty acids within the adipose tissue, and diet, which will
alter the fatty acid profile of the adipose tissue. Although
the former has been examined extensively, particularly
with regard to leptin expression and adipocyte differenti-
ation, the effects of the latter on endocrine function have
only recently begun to be investigated.
Adiponectin is the most highly expressed and secreted
adipokine, with beneficial effects on metabolism, inflam-
mation, and vascular function. Adiponectin has a para-
doxical expression pattern. As adiposity increases,
adiponectin expression and secretion decreases within the
adipose tissue [2]. It is believed that this paradox is part of
the pathology of obesity, and is symptomatic of dysfunc-
tional adipose tissue. Adiponectin plays a role in insulin
sensitivity, LDL oxidation, eNOS activation, inflammation
suppression and fatty acid catabolism [3–5]. Thus, hypoa-
diponectinemia is of interest as a biomarker of both car-
diovascular disease and metabolic syndrome.
Another important adipokine that could be stimulated by
changes in fatty acid profile is leptin. It was first discovered
as the protein encoded by the obese gene, named for the
phenotype of the double knockout mouse. These mice
experience no satiety, and thus eat continuously when fed
ad libitum, leading to severe diet-induced obesity. In
humans, leptin deficiency has been implicated in cases of
morbid obesity, as either a genetic factor or a metabolic
insufficiency [6, 7]. Leptin’s role in hypothalamic-medi-
ated appetite suppression in response to caloric intake is
not its only function. Leptin may also be important in the
modulation of T cell activity in the early stages of ath-
erosclerotic development as well as other immune cells [8].
In obesity, leptin may be under-expressed by the adipose
tissue in response to a consistently high caloric diet, or,
leptin receptors may be down-regulated, thus leading to
high plasma leptin levels and leptin resistance [9].
Flaxseed has recently gained popularity as a functional
food. Alpha-linolenic acid (ALA) comprises approximately
55% of the total fatty acid content of flaxseed fatty acids
[10]. ALA-rich diets, including diets enriched with ground
flaxseed, have been shown in interventional and experi-
mental trials to reduce both fatal and non-fatal myocardial
infarction [11, 12], cardiac arrhythmias [12–15], and the
incidence of atherosclerotic lesions [12, 14, 16, 17].
However, the mechanism whereby ALA and flaxseed
induce this cardio-protective action is unclear. Previous
data have indicated that ALA from a flaxseed enriched diet
is deposited in adipose tissue [18]. It is possible, therefore,
that this change in adipose tissue fatty acid content may
influence adipose tissue function. We hypothesize that the
change in lipid composition in adipose tissue in response to
a flaxseed supplemented diet may affect the adipokine
signaling from the adipocytes. It is possible, therefore, that
the beneficial cardiovascular actions of flaxseed previously
observed may be associated with changes in adipokine
expression.
Materials and Methods
Diet and Feeding
All experiments were conducted in accordance with the
guidelines of the Canadian Council on Animal Care.
Sixteen male New Zealand White rabbits (2.8 ± 0.1 kg,
Southern Rose Rabbitry) were randomly assigned to
receive one of four diets. Diets were prepared as previ-
ously described [15, 17] by the addition of components
to a regular (RG) rabbit diet (CO-OP Complete Rabbit
Ration, Federated Co-operatives): 0.5% cholesterol (CH),
or 10% ground flaxseed (FX), or both (CF) for 8 weeks
(n = 4). The chow was stored at 4 C and protected from
light. The diets differed only in total fat content due to
the inclusion of the naturally ALA-rich ground flaxseed
(Tables 1, 2). The diet fatty acid composition is outlined
in Table 2. Addition of flaxseed to the diet significantly
increased the amount of C16:0, C18:0, C18:1 (oleic acid)
and C18:3 (ALA) provided. The addition of cholesterol
had no significant effect on dietary fatty acids provided
in comparison to the RG diet. Rabbits were fed 125 g/
day of the diet.
Table 1 Crude dietary composition
RG FX CH CF
Crude protein (%) 21.3 20.5 20.4 20.5
Carbohydrates (%) 51.4 51.7 52.5 50.6
Crude fat (%) 5.4 8.1 5.2 8.9
Crude fibre (%) 13.5 11.7 13.6 12.4
Ash (%) 8.4 8.1 8.1 7.7
ALA (mg/g of diet) 2.0 20.0 2.1 22.5
Digestible energy (kcal/g) 3.38 3.56 3.37 3.60
RG regular diet, FX 10% flaxseed supplemented diet, CH 0.5%
cholesterol supplemented diet, CF 10% flaxseed and 0.5% cholesterol
supplemented diet
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Blood Sampling and Analysis
Blood was drawn from the left marginal ear vein of rabbits
that were fasted overnight before starting their experi-
mental diets and at 8 weeks. It was collected in vacutainer
tubes containing EDTA (Becton–Dickinson). Blood sam-
ples were centrifuged at 4,5009g at room temperature for
10 min, and plasma was then stored at -80 C. Before
analysis, plasma samples were thawed and centrifuged at
6,8009g. Plasma levels of cholesterol and triglycerides
were analyzed using a VetTest 8008 blood chemistry
analyzer (IDEXX Laboratories). Fatty acids were extracted
from plasma and derivatized, as described previously [15,
18].
Tissue Collection
After 8 weeks of dietary treatment, animals were eutha-
nized by 5% isoflurane gas delivered by face mask, fol-
lowed by cardiac extraction. Retroperitoneal and
epididymal adipose tissue were collected. To prevent
RNase contamination, the animal and tools were sprayed
with RNaseZap (Ambion) both before and during tissue
collection. Adipose tissue was immediately placed in
RNAlater, and kept overnight at 4 C, as indicated in the
manufacturer’s instructions (Ambion). Preliminary testing
indicated that there was successful stabilization of mRNA
compared to flash freezing or maintenance overnight at
4 C (as assessed by agarose gel electrophoresis and sub-
sequent qRT-PCR) despite the high lipid content of this
tissue. RNAlater was removed from the tissue by suction,
and the samples were then flash frozen in liquid nitrogen
and stored at -80 C.
qRT-PCR
RNA was extracted from the adipose tissue in an RNase-free
environment. Adipose tissue was homogenized in Trizol
reagent (Invitrogen), and fat was removed. Phenol was sep-
arated from the solution by washing the solution twice with
chloroform. The RNA was precipitated from solution with
ethanol, and added to RNeasy columns for further purification
(Qiagen). Extracted RNA was quantified and assessed for
quality by spectrophotometer and agarose gel electrophoresis.
It was then used for qRT-PCR (Quanta Biosystems) using a
iQ5 Real-Time PCR Detection System (Bio-Rad). Primers
designed using BLAST software (NCBI) and were as follows:
Adiponectin: (Forward 50ACCAGGACAAGAACGTGG
AC30, Reverse 50TGGAGATGGAATCGTTGACA30);
Leptin: (Forward 50GTCGTCGGTTTGGACTTCATC30,
Reverse 50CGGAGGTTCTCCAGGTCGTTG30) [19];
GAPDH: (Forward 50GATGGTGAAGGTCGGAG
TGAA30, Reverse 50GGTGAAGACGCCAGTGGATT30)
[20].
Primers were validated using NCBI’s BLAST software
[21]. Unused samples were stored at -80 C. cDNA was
synthesized from 1 ug of RNA with qScript cDNA Su-
permix (Quanta) via the manufacturer’s directions. qPCR
proceeded for 2 min at 50 C, 95 C for 8.5 min, then 40
cycles of 95 C for 15 s and 60 C for 60 s, at which point
the data were captured. A melt curve was obtained after
cycling with 95 C for 1 min followed by 55 C for 1 min,
Table 2 Fatty acid composition
of rabbit diets
Values are means ± SE, as mg
of lipid/g of diet. Fatty acids
were extracted from rabbit chow
RG regular fed, FX 10%
flaxseed fed, CH 0.5%
cholesterol fed, CF 0.5%
cholesterol plus 10% flaxseed
fed, ND not detectable amounts
present
* p \ 0.05 versus RG
^ p \ 0.05 versus FX
FAME (mg/g) RG FX CH CF
C14:0 0.293 ± 0.014 0.371 ± 0.013 0.267 ± 0.002 0.337 ± 0.016
C14:1 0.131 ± 0.001 ND 0.033 ± 0.033 ND
C16:0 6.502 ± 0.247 9.567 ± 0.349* 6.338 ± 0.044 9.364 ± 0.232*
C16:1 0.403 ± 0.024 0.540 ± 0.031 0.354 ± 0.001 0.442 ± 0.004
C18:0 2.200 ± 0.147 3.942 ± 0.157* 2.048 ± 0.006 3.643 ± 0.186*
C18:1 Ol 10.693 ± 0.325 17.055 ± 0.862* 10.292 ± 0.010 16.361 ± 0.840*
C18:1 Vac 1.719 ± 0.148 2.775 ± 0.002* 1.644 ± 0.064 2.611 ± 0.067
C18:2 LA 11.191 ± 0.343 11.781 ± 0.513 12.328 ± 0.170 13.713 ± 0.490
C20:0 0.113 ± 0.011 0.165 ± 0.009 0.117 ± 0.001 0.159 ± 0.025
C18:3n-6 GLA ND 0.115 ± 0.002 ND 0.125 ± 0.004
C20:1 ND ND ND ND
C18:3n-3 ALA 1.993 ± 0.120 20.077 ± 0.841* 2.119 ± 0.036 22.535 ± 0.679*^
C20:2 0.092 ± 0.012 0.125 ± 0.009 0.087 ± 0.002 0.106 ± 0.007
C22:0 0.160 ± 0.012 0.196 ± 0.002 0.166 ± 0.006 0.199 ± 0.036
C22:1 0.112 ± 0.032 0.292 ± 0.009 0.095 ± 0.009 0.094 ± 0.042
C20:3 ND ND ND 0.193 ± 0.003
C22:6 DHA ND ND 0.105 ± 0.105 0.115 ± 0.115
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and 80 10-s capture cycles of 55 ? 0.5 C/cycle. Results
were normalized by GAPDH expression and analyzed by
the delta–delta-Ct method using iCycler Real-Time
Detection Software.
Fatty Acid Extraction and Methylation
Plasma fatty acids were directly extracted and derivatized
using a modification of the original method described by
Lepage and Roy [22] and later modified by Garg et al. [23].
Briefly, 100 lL of plasma was combined with 2 mL of 4:1
(v/v) methanol:toluene in a borosilicate glass tube. The
methanol:toluene solution contained 0.5 mg/ml of the
internal standard, C19:0 (Nu-Chek Prep. Inc.). While vor-
texing, 200 lL of acetyl chloride was slowly added. Tubes
were capped with a Teflon lined lid, weighed and then
heated at 100 C for 1 h. Once cooled to room temperature,
tubes were re-weighed to ensure no sample loss had
occurred. Five milliliters of an aqueous 6% K2CO3 solution
was then added to terminate and neutralize the reaction. The
sample tube was then centrifuged at 5,000 rpm for 5 min at
room temperature after which the upper toluene layer was
removed and subjected to gas chromatographic analysis
using flame ionization detection (GC-FID). Methylation
was verified by thin layer chromatography. Fatty acids from
approximately 15 mg of adipose tissue were extracted and
derivatized using the method outlined by Lepage and Roy
[24].
Gas Chromatography
Fatty acid methyl esters (FAME) were injected onto a Varian
CP 3800 gas chromatographic system using a Varian CP 8400
autosampler. Analytes were detected using flame ionization
detection and analyzed on a Varian MS Workstation (vrs.
6.9.1). One microliter of sample was injected at 250 C at a
split ratio of 50:1 onto a Varian CP-Sil 88 capillary column
(60 m 9 0.25 mm 9 0.20 lm). Helium gas (ultra pure) was
used as the carrier gas at a constant flow rate of 1.5 mL/min.
The oven temperature was maintained at 111 C for 1 min
then rapidly increased by 20 C/min to 170 C. It was then
slowly increased at a rate of 5 C/min to 190 C and finally by
3 C/min up to 225 C where it was maintained for 10 min.
FAME were quantified against an external standard, GLC
462 (Nu-Chek Prep, Inc.).
Quantification of Aortic Atherosclerosis
The aorta from the ascending arch to the iliac bifurcation
was isolated from peripheral tissues and washed in cold
PBS, then opened longitudinally and pinned flat. The aortic
lumen was digitally photographed and luminal images
were analyzed with Silicon Graphics Imaging software.
Fatty streaks and complicated lesions were expressed as a
percentile of total luminal surface area.
Statistics
Results were reported as means ± SE, and analyzed with
Sigma-Stat software by one-way ANOVA, using Fisher’s
LSD test. A significant correlation was identified by a t test.
p B0.05 was considered statistically significant.
Results
Body Weight
After 8 weeks of dietary treatment, mean body weight
significantly increased from 2.8 ± 0.06 to 3.7 ± 0.09 kg.
However, there was no effect on weight with the experi-
mental diets as compared to control diets (data not shown).
Plasma Lipids
There was no significant change in the plasma cholesterol
of animals fed a regular or flaxseed supplemented diet after
8 weeks. Supplementation of the diet with dietary choles-
terol for 8 weeks induced severe hypercholesterolemia
(Fig. 1a). Addition of dietary flaxseed to a cholesterol-
enriched diet did not lower the plasma cholesterol values
from those observed in animals fed a diet supplemented
with cholesterol alone.
Plasma triglycerides were not significantly affected by
any of the diets (Fig. 1b). Addition of milled flaxseed to the
diet, providing ALA, induced a 17-fold increase in the
percentage composition of ALA in the plasma (Fig. 1c).
Simultaneous consumption of flaxseed and cholesterol
doubled the amount of ALA in the plasma as compared to
the consumption of flaxseed alone, comprising 21% of all
plasma fatty acids. an eightfold increase in plasma ALA,
despite being provided with only 2 mg of ALA/gram,
supporting the observation that cholesterol aids in absorp-
tion of ALA [15–18].
Atherosclerosis
Animals fed a regular or flaxseed-supplemented diet for
8 weeks did not develop any quantifiable atherosclerosis in
the aortic arch (Fig. 2). Inclusion of 0.5% cholesterol in the
diet induced atherosclerotic lesions in the aorta, covering
76.3 ± 8.5% of the aortic lumen (p \ 0.05 vs. RG, n = 3).
Addition of ground flaxseed to the cholesterol-supple-
mented diet ameliorated the atherogenic effects of cho-
lesterol, significantly reducing lesions to 28 ± 4.3% of the
aortic lumen (p \ 0.05 vs. CH, n = 3).
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Fatty Acid Composition of Adipose Tissue
Total lipids were extracted from two primary sources of
visceral fat. Epididymal and retroperitoneal fat consisted of
92.24% lipid by wet weight (range 83.3–99.5%), with no
significant changes in total lipid between different dietary
treatments, or either adipose source (Tables 3, 4).
The main component of adipose tissue was C18:1, oleic
acid, which composed 32.3 ± 1.9% of total fatty acids in the
retroperitoneal adipose of RG-fed animals (Table 3). C16:0,
palmitic acid, and C18:2, linoleic acid, were also common,
comprising 25.2 ± 1.4 and 26.7 ± 1.3% of the total retro-
peritoneal adipose tissue fatty acid content, respectively. Also
stored in appreciable quantities in the retroperitoneal adipose
tissue of animals fed a regular diet were ALA
(6.34 ± 0.34%), steric acid (6.14 ± 0.57%), palmitoleic
acid (2.12 ± 0.08%), vaccenic acid (1.98 ± 0.21%), and
myristic acid (1.77 ± 0.12%) (Table 3).
The fatty acid proportions in the epididymal tissue of the
animals fed a regular diet were not significantly different
than the proportions of fatty acid in retroperitoneal tissue
(Table 4). Dietary cholesterol did not significantly affect
either total lipids or individual fatty acids as compared to RG.
Addition of flaxseed to a regular diet significantly reduced
levels of C16:0, C18:1-cis, C18:1-trans, and C18:2 in the
adipose tissue, both in absolute concentrations and relative to
total fatty acid content (Tables 3, 4). When consumed in
conjunction with 0.5% cholesterol, dietary flaxseed induced
a 3.1-fold increase in adipose tissue ALA, a significant
increase as compared to RG, but significantly less than ani-
mals supplemented only with flaxseed. Dietary cholesterol
did not affect any of the other fatty acids observed.
Adipokine Expression
Adiponectin and leptin are the two most highly expressed
adipokines in adipose tissue. In epididymal adipose tissue,
there was no significant change in either leptin or adipo-
nectin mRNA expression after addition of either flaxseed
or cholesterol to the diet (Fig. 3a). Adiponectin expression
did not vary with dietary treatment in retroperitoneal adi-
pose tissue (Fig. 3b). However, in retroperitoneal adipose
tissue, dietary flaxseed induced a two-fold increase in
leptin mRNA (p \ 0.05 vs. RG). Conversely, dietary
cholesterol reduced leptin mRNA expression by about one-
half in comparison to control, and the addition of flaxseed
to the cholesterol-supplemented diet induced a recovery of
leptin expression, increasing expression beyond that of
flaxseed alone.
Fig. 1 Plasma cholesterol (a), triglycerides (b), and alpha-linolenic
acid (c) levels in male New Zealand White rabbits at baseline and
after 8 weeks of dietary treatment. *p \ 0.05 versus RG; n = 3–4.
RG regular chow, FX chow supplemented with 10% flaxseed, CH
0.5% cholesterol-supplemented diet, CF 10% flaxseed and 0.5%
cholesterol-supplemented diet
Fig. 2 Development of atherosclerotic lesions on the aorta of New
Zealand White rabbits after 8 weeks of dietary treatment. Values are
means ± SE; n = 3. *p B 0.05 versus RG; p B 0.05 versus CH. RG
regular chow, FX chow supplemented with 10% flaxseed, CH 0.5%
cholesterol-supplemented diet, CF 10% flaxseed and 0.5% choles-
terol-supplemented diet
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These changes in leptin expression were positively
correlated with plasma ALA and adipose ALA levels
(Fig. 4). Plasma ALA correlated with leptin expression in
the retroperitoneal adipose tissue (p \ 0.05), but not in
epididymal adipose (Fig. 4a). Adipose tissue ALA exhib-
ited a stronger relationship than plasma ALA with leptin
expression in retroperitoneal adipose tissue (Fig. 4b).
Relationship of Leptin Expression to Atherosclerosis
All animals that were not fed cholesterol did not exhibit any
atherosclerosis. Consequently, in order to determine if there
was a significant relationship between leptin expression and
the development of atherosclerotic lesions, linear regression
was performed only on data obtained from animals fed a
cholesterol-supplemented diet. Increased leptin expression in
the retroperitoneal adipose tissue significantly correlated
(p \ 0.05) with decreased atherosclerosis (Fig. 5).
Discussion
One of the primary purposes of this study was to determine
if diets of very different lipid composition could influence
the expression of leptin or adiponectin in adipose tissue
when caloric balance was maintained. It is known that
leptin expression varies with caloric balance and adiposity
[25–28]. The present study was designed to avoid these
potential variables by maintaining the diets in a manner
which maintained a consistent level of caloric intake while
at the same time insuring diversity in lipid composition.
The differences in caloric values between the diets were so
minor that they did not induce a significant change in body
weight. The data obtained in the present study demon-
strates that the lipid composition of the diet can have an
important role to play in adipokine expression. The chan-
ges in adipokine expression were sensitive to the type of
lipid in the diet, the adipose tissue examined and the
Table 3 Fatty acids in
retroperitoneal adipose tissue
from rabbits fed diets for
8 weeks
Values are means ± SE. Fatty
acids were extracted from
retroperitoneal adipose tissue
following 8 weeks of feeding
(n = 4)
RG regular fed, FX 10%
flaxseed fed, CH 0.5%
cholesterol fed, CF 0.5%
cholesterol plus 10% flaxseed
fed, ND not detectable amounts
present, TL total mg lipids
extracted per mg of tissue
* p \ 0.05 versus RG
^ p \ 0.05 versus FX
FAME (lmol/g) Retroperitoneal adipose tissue
RG FX CH CF
10:0 ND ND ND ND
12:0 ND ND 1.54 ± 0.94 1.45 ± 0.87
12:1 ND ND ND ND
14:0 74.40 ± 4.00 50.91 ± 6.76* 66.17 ± 2.12 60.90 ± 1.84
14:1 ND ND ND ND
16:0 945.68 ± 37.82 699.88 ± 15.45* 905.45 ± 40.17 773.21 ± 25.07*
16:1 81.17 ± 7.50 46.95 ± 6.42 90.90 ± 10.74 83.39 ± 13.85
18:0 195.76 ± 12.98 169.31 ± 8.66 179.48 ± 6.93 169.35 ± 4.22
18:1 n-9 1,104.79 ± 75.25 821.93 ± 49.73* 981.88 ± 20.87 962.26 ± 21.53
18:1 trans 67.80 ± 7.42 42.39 ± 3.38* 55.96 ± 1.62 49.30 ± 1.26*
18:2 n-6 878.82 ± 26.06 705.14 ± 35.87* 938.47 ± 69.49 778.75 ± 19.54
20:0 0.51 ± 0.38 0.45 ± 0.24 0.88 ± 0.45 ND
18:3 n-6 ND ND ND ND
18:3 n-3 218.96 ± 7.95 895.96 ± 63.33* 184.22 ± 6.98 672.52 ± 78.99*^
20:1 14.49 ± 1.69 11.83 ± 1.16 12.46 ± 1.29 11.14 ± 1.40
20:2 1.68 ± 0.57 0.27 ± 0.18 1.31 ± 0.51 0.60 ± 0.23
22:0 ND ND ND ND
20:3 n-6 ND ND ND ND
20:3 n-3 ND 5.76 ± 0.89 ND 3.32 ± 0.80
22:1 0.68 ± 0.28 0.22 ± 0.15 0.43 ± 0.26 0.83 ± 0.62
20:4 n-6 0.76 ± 0.44 0.38 ± 0.89 1.28 ± 0.75 0.83 ± 0.48
C22:2 ND ND ND ND
C20:5 n-3 ND ND ND ND
C24:0 ND ND ND ND
C24:1 ND ND ND ND
C22:4 ND ND ND ND
C22:5 ND 0.58 ± 0.45 ND 0.48 ± 0.2
C22:6 ND ND ND ND
TL (%) 90.5 ± 0.23 91.4 ± 3.70 95.7 ± 2.02 94.4 ± 1.35
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adipokine studied as well. A high cholesterol diet sup-
pressed leptin expression whereas a diet rich in the omega-
3 fatty acid ALA increased leptin expression. Leptin
expression was influenced by the diets whereas adiponectin
was not. Retroperitoneal but not epididymal adipose tissue
was affected by the diets. It is known that the location of
the different adipose tissues will influence circulating
adipokine levels [29].
The mechanism whereby leptin mRNA expression is
regulated by dietary lipids is presently unclear. Although
SREBP1c mRNA expression is directly related to poly-
unsaturated fatty acid content in adipose tissue [30] and an
SREBP-like binding element is present in the leptin pro-
moter, it is not responsive to SREBP itself [31]. However,
polyunsaturated fatty acids may act as ligands for PPAR
gamma to alter adipokine expression [32]. This may occur
through an increase in translation [33]. Mason et al. [28]
have demonstrated a novel binding site for an adipocyte-
specific transcription factor in the -87 position of the leptin
promoter which is conserved in both mice and humans,
however, the consensus sequence does not match any
known transcription factor. This region, termed LP1, pre-
sents an interesting possibility for a novel transcription
factor which may regulate the response of leptin to dietary
lipids in addition to PPAR-gamma.
The observation that the adipose tissue is responding to
these diets in a very specific manner suggests that the
changes are physiologically important. Increased leptin
levels have been identified previously as a risk factor for
atherosclerosis [34]. However, data correlating leptin and
atherosclerosis have been derived from obese humans and
animal models of obesity [35–39]. Our data indicates that
in a non-obese population, leptin may have a previously
unidentified role in cardioprotection. In support of this
hypothesis, leptin expression was significantly correlated in
a negative fashion with atherosclerosis. When leptin levels
Table 4 Fatty acids in
epididymal adipose tissue from
rabbits fed diets for 8 weeks
Values are means ± SE. Fatty
acids were extracted from
epididymal adipose tissue
following 8 weeks of feeding
(n = 4)
RG regular fed, FX 10%
flaxseed fed, CH 0.5%
cholesterol fed, CF 0.5%
cholesterol plus 10% flaxseed
fed, ND not detectable amounts
present, TL total mg lipids
extracted per mg of tissue
* p \ 0.05 versus RG
^ p \ 0.05 versus FX
FAME (lmol/g) Epididymal adipose tissue
RG FX CH CF
10:0 ND ND ND ND
12:0 ND 1.13 ± 0.85 2.48 ± 1.70 ND
12:1 ND ND ND ND
14:0 79.12 ± 3.28 59.37 ± 4.65 68.03 ± 4.33 57.85 ± 7.95
14:1 0.99 ± 0.52 ND ND ND
16:0 919.51 ± 32.27 676.35 ± 20.48* 862.90 ± 46.25 743.00 ± 44.11*
16:1 101.26 ± 11.89 64.76 ± 10.31 89.76 ± 14.79 92.60 ± 21.24
18:0 193.31 ± 7.60 162.54 ± 6.79 169.93 ± 11.23 158.20 ± 7.84
18:1 n-9 1,122.28 ± 38.65 889.86 ± 29.71* 925.11 ± 25.28 917.13 ± 73.87*
18:1 trans 69.78 ± 6.12 48.23 ± 1.50* 54.66 ± 3.68 49.07 ± 5.21*
18:2 n-6 893.65 ± 36.57 694.95 ± 22.56* 887.65 ± 17.06 789.54 ± 40.46
20:0 0.88 ± 0.45 ND 1.16 ± 0.61 1.27 ± 0.30
18:3 n-6 ND ND ND ND
18:3 n-3 219.61 ± 7.33 916.35 ± 27.84* 176.76 ± 6.12 569.80 ± 96.29*^
20:1 15.06 ± 1.53 12.81 ± 0.92 11.97 ± 0.45 12.26 ± 0.26
20:2 1.13 ± 0.40 0.48 ± 0.28 0.98 ± 0.57 ND
22:0 ND ND ND ND
20:3 n-6 ND ND ND ND
20:3 n-3 ND 6.58 ± 2.16 ND 0.96 ± 0.81
22:1 1.67 ± 0.64 ND 1.83 ± 0.54 1.78 ± 0.34
20:4 n-6 ND ND ND ND
C22:2 ND ND ND ND
C20:5 n-3 ND ND ND ND
C24:0 ND ND ND ND
C24:1 ND ND ND ND
C22:4 ND ND ND ND
C22:5 ND ND ND ND
C22:6 ND ND ND ND
TL (%) 93.2 ± 2.87 90.5 ± 4.11 88.1 ± 3.36 94.1 ± 2.18
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were high, atherosclerosis was low and when leptin
expression was depressed by circulating cholesterol, ath-
erogenesis was stimulated.
Consumption of flaxseed has previously been shown to
improve insulin resistance, hyperlipidemia, atherosclerosis
and hypertension and decrease the incidence of cardiac
arrhythmias [15–17, 40]. These effects of dietary flaxseed
have been attributed, in part, to the rich ALA content of
flaxseed [15–17, 40]. Dietary flaxseed provided a source of
ALA in the present study which subsequently increased
ALA both in the circulation and in the adipose tissue. With
the addition of cholesterol to the flaxseed-supplemented
diet, plasma ALA increased substantially but adipose tissue
levels of ALA did not exhibit further increase beyond those
observed when the diet was supplemented with flaxseed
alone (Table 3). This could be due to one of several factors.
ALA may be deposited in other organs preferentially, such
as the heart and liver, as previously observed in the
hypercholesterolemic rabbit [18]. Alternatively, a choles-
terol-rich diet may direct the ALA to be used directly for
beta-oxidation, thus reducing the amount of ALA available
for storage [41]. Cholesterol may also induce an efflux of
ALA from the adipose tissue, which is greater than the
influx of ALA from the plasma, leading to a net decrease in
ALA [42]. Further study is required to understand the
relative lack of storage of ALA in the adipose tissue when
it is presented with such high levels of circulating ALA.
Both beneficial and deleterious cytokines from the adi-
pose tissue may be responsible for many of the links
between diet, BMI and cardiovascular disease. The present
data demonstrate that dietary cholesterol and flaxseed have
Fig. 3 mRNA expression of adiponectin (a) or leptin (b) in epidid-
ymal and retroperitoneal adipose tissue of New Zealand White rabbits
after 8 weeks of dietary treatment, measured by quantitative real-time
PCR. Values were normalized by GAPDH expression and expressed
as means ± SE; n = 3–4. *p \ 0.05. RG regular chow, FX chow
supplemented with 10% flaxseed, CH 0.5% cholesterol-supplemented
diet, CF 10% flaxseed and 0.5% cholesterol-supplemented diet
Fig. 4 Correlational analysis of expression of leptin mRNA from
retroperitoneal adipose tissue with plasma alpha-linolenic acid (a),
and adipose alpha-linolenic acid (b) of New Zealand White rabbits
after 8 weeks of dietary treatment. a *p \ 0.05; b p \ 0.05
Fig. 5 Correlational analysis of the percentage of the aortic lumen
covered with atherosclerotic plaque with leptin mRNA from retro-
peritoneal adipose tissue of hypercholesterolemic New Zealand White
rabbits after 8 weeks of atherogenic dietary treatment. *p \ 0.05
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the capacity to alter leptin expression. The cardioprotective
effects of flaxseed are thought to be provided in part by its
delivery of ALA to the body [16, 40]. However, the
mechanism to explain the induction of these effects by
ALA remains elusive. In the present study, ALA in the
adipose tissue was strongly associated with increased leptin
expression and the subsequent reduction of atherosclerosis.
Our data, therefore, suggests that flaxseed may induce its
anti-atherogenic effects in part via an ALA-mediated
modulation of the expression of leptin.
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